Cargando…

Effects of adjunctive pimavanserin and current antipsychotic treatment on QT interval prolongation in patients with schizophrenia

BACKGROUND: Pimavanserin prolongs the QT interval, with mean increases in corrected QT (QTc) of 5–8 ms, and is currently being investigated for the treatment of negative symptoms of schizophrenia. OBJECTIVES: To assess QT interval prolongation in 3 studies investigating once-daily pimavanserin as an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bugarski-Kirola, Dragana, Nunez, Rene, Odetalla, Ramzey, Liu, I-Yuan, Turner, Mary Ellen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486460/ https://www.ncbi.nlm.nih.gov/pubmed/36147980 http://dx.doi.org/10.3389/fpsyt.2022.892199

Ejemplares similares

T41. SAFETY PROFILE OF ADJUNCTIVE PIMAVANSERIN IN THE ENHANCE STUDY, A PHASE 3 TRIAL FOR THE POTENTIAL TREATMENT OF SCHIZOPHRENIA IN PATIENTS WITH AN INADEQUATE RESPONSE TO ANTIPSYCHOTIC TREATMENT
por: Bugarski-Kirola, Dragana, et al.
Publicado: (2020)

T42. HIGH ADHERENCE TO CURRENT ANTIPSYCHOTIC AND ADJUNCTIVE PIMAVANSERIN IN THE ENHANCE STUDY, A PHASE 3 TRIAL TO EVALUATE THE TREATMENT OF SCHIZOPHRENIA IN PATIENTS WITH AN INADEQUATE RESPONSE TO ANTIPSYCHOTIC TREATMENT
por: Abbs, Brandon, et al.
Publicado: (2020)

Pimavanserin Exposure-Response Analyses in Patients With Schizophrenia: Results From the Phase 2 ADVANCE Study
por: Darwish, Mona, et al.
Publicado: (2022)

Genetic Biomarkers of Antipsychotic-Induced Prolongation of the QT Interval in Patients with Schizophrenia
por: Vaiman, Elena E., et al.
Publicado: (2022)

Coprescription of QT interval-prolonging antipsychotics with potentially interacting medications in Thailand
por: Waleekhachonloet, Onanong, et al.
Publicado: (2019)

Cognitive Behavioral Therapy for Insomnia as Adjunctive Therapy to Antipsychotics in Schizophrenia: A Case Report
por: Izuhara, Muneto, et al.
Publicado: (2018)

Antipsychotic Medication and QT Prolongation
por: Chohan, Paramdip Singh, et al.
Publicado: (2015)

Comparison of Antipsychotics for the Treatment of Patients With Delirium and QTc Interval Prolongation: A Clinical Decision Analysis
por: Kurisu, Ken, et al.
Publicado: (2021)

Effects of Antipsychotics on Arrhythmogenic Parameters in Schizophrenia Patients: Beyond Corrected QT Interval
por: Okayasu, Hiroaki, et al.
Publicado: (2021)

Mortality in Patients with Parkinson’s Disease-Related Psychosis Treated with Pimavanserin Compared with Other Atypical Antipsychotics: A Cohort Study
por: Layton, J. Bradley, et al.
Publicado: (2022)

Falls and Fractures in Patients with Parkinson’s Disease-Related Psychosis Treated with Pimavanserin vs Atypical Antipsychotics: A Cohort Study
por: Layton, J. Bradley, et al.
Publicado: (2021)

Effect of QT interval-prolonging drugs taken in pregnancy on the neonatal QT interval
por: Michel, Holger, et al.
Publicado: (2023)

Beyond a prolonged QT interval
por: Bitar, Zouheir Ibrahim, et al.
Publicado: (2013)

Hydroxychloroquine-associated QT interval prolongation
Publicado: (2020)

Safety and Efficacy of High-Dose Vitamin B6 as an Adjunctive Treatment for Antipsychotic-Induced Hyperprolactinemia in Male Patients With Treatment-Resistant Schizophrenia
por: Zhuo, Chuanjun, et al.
Publicado: (2021)

Multifactorial QT Interval Prolongation and Takotsubo Cardiomyopathy
por: Gysel, Michael, et al.
Publicado: (2014)

QT interval prolongation with hydroxychloroquine plus azithromycin
Publicado: (2020)

Azithromycin: QT interval prolongation: case report
Publicado: (2021)

Chloroquine: QT interval prolongation: case report
Publicado: (2021)

Prolonged QT Interval in Cirrhosis: Twisting Time?
por: Lee, William, et al.
Publicado: (2022)

Determinants of severe QT(c) prolongation in a real-world gerontopsychiatric setting
por: Schulze Westhoff, Martin, et al.
Publicado: (2023)

The Therapeutic Potential of Mangosteen Pericarp as an Adjunctive Therapy for Bipolar Disorder and Schizophrenia
por: Ashton, Melanie M., et al.
Publicado: (2019)

Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia
por: MacKenzie, Nicole E., et al.
Publicado: (2018)

Hypofunctional Dopamine Uptake and Antipsychotic Treatment-Resistant Schizophrenia
por: Amato, Davide, et al.
Publicado: (2019)

Influence of antipsychotics on metabolic syndrome risk in patients with schizophrenia
por: Koricanac, Aleksandra, et al.
Publicado: (2022)

Readmission Rates of Patients with Schizophrenia Treated with Depot Antipsychotics versus Oral Antipsychotics in a Community Hospital
por: Espiridion, Eduardo D, et al.
Publicado: (2018)

Prolonged QT interval in a man with anorexia nervosa
por: Macías-Robles, María Dolores, et al.
Publicado: (2009)

Correlation between seizure in children and prolonged QT interval
por: Sadrnia, Saeid, et al.
Publicado: (2013)

Pharmacogenetics of Drug-Induced QT Interval Prolongation: An Update
por: Niemeijer, Maartje N., et al.
Publicado: (2015)

Azithromycin/hydroxychloroquine: Prolongation of the QT interval: case report
Publicado: (2020)

New antipsychotic drugs for the treatment of agitation and psychosis in Alzheimer’s disease: focus on brexpiprazole and pimavanserin
por: Caraci, Filippo, et al.
Publicado: (2020)

Aging effects on QT interval: Implications for cardiac safety of antipsychotic drugs
por: Rabkin, Simon W.
Publicado: (2014)

Antipsychotic Dose Mediates the Association between Polypharmacy and Corrected QT Interval
por: Barbui, Corrado, et al.
Publicado: (2016)

Adjunctive Magnetic Seizure Therapy for Schizophrenia: A Systematic Review
por: Zhang, Xin-Yang, et al.
Publicado: (2022)

Case Report: High doses of Zolpidem and QT interval lengthening: Is there a relationship? A case series
por: Campagnari, Simone, et al.
Publicado: (2022)

Psychometric evaluation of the Work Readiness Questionnaire in schizophrenia
por: Potkin, Steven G., et al.
Publicado: (2014)

QT Interval Prolongation in Patients with Systemic Sclerosis—Are the Holter ECG Recordings a Better Option for QT Interval Evaluation?
por: Saramet, Elena E., et al.
Publicado: (2021)

Brain Networks Reveal the Effects of Antipsychotic Drugs on Schizophrenia Patients and Controls
por: Towlson, Emma K., et al.
Publicado: (2019)

Antipsychotics-induced improvement of cool executive function in individuals living with schizophrenia
por: Si, Yajing, et al.
Publicado: (2023)

HARMONY Study: Pimavanserin Significantly Prolongs Time to Relapse of Dementia-Related Psychosis
por: Tariot, Pierre, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6ou6prct4lu2cp2ekep6mqj55t